Detecting and Estimating Contamination of Human DNA Samples in Sequencing and Array-Based Genotype Data  by Jun, Goo et al.
ARTICLE
Detecting and Estimating Contamination of Human DNA
Samples in Sequencing and Array-Based Genotype Data
Goo Jun,1,3 Matthew Flickinger,1,3 Kurt N. Hetrick,2 Jane M. Romm,2 Kimberly F. Doheny,2
Gonc¸alo R. Abecasis,1 Michael Boehnke,1 and Hyun Min Kang1,*
DNA sample contamination is a serious problem in DNA sequencing studies andmay result in systematic genotypemisclassification and
false positive associations. Although methods exist to detect and filter out cross-species contamination, few methods to detect within-
species sample contamination are available. In this paper, we describe methods to identify within-species DNA sample contamination
based on (1) a combination of sequencing reads and array-based genotype data, (2) sequence reads alone, and (3) array-based genotype
data alone. Analysis of sequencing reads allows contamination detection after sequence data is generated but prior to variant calling;
analysis of array-based genotype data allows contamination detection prior to generation of costly sequence data. Through a combina-
tion of analysis of in silico and experimentally contaminated samples, we show that our methods can reliably detect and estimate levels
of contamination as low as 1%. We evaluate the impact of DNA contamination on genotype accuracy and propose effective strategies to
screen for and prevent DNA contamination in sequencing studies.Introduction
Advances in array-based genotyping and next-generation
sequencing have resulted in higher throughput, lower
costs, and reduced error rates. These technologies enable
increasingly comprehensive genetic studies for a wide
range of human diseases and traits. Although they are
constantly improving, genotyping and sequencing tech-
nologies are not perfect, and careful attention must be
paid to ensure high data quality. Sensitive and efficient
methods to screen data for potential artifacts are critical.
One potential source of error is DNA sample contamina-
tion. Because samples are often processed in batches and
genotyping and sequencing protocols require multiple
steps of sample handling and manipulation in the lab, it
is not surprising that DNA from more than one individual
may end up in the same well or prepared library. In this
paper, we focus on within-species contamination in
which DNA from more than one individual is present,
either from another individual in the same study or from
an unknown individual. Note that cross-species contami-
nation can often be detected and filtered out during the
alignment of sequence reads.1 Within species contamina-
tion is harder to detect and can result in greatly reduced
genotype quality for sequencing studies; the problem is
most severe for low pass sequencing studies (where each
allele is typically supported by only a few reads) but can
affect even deep sequencing studies.
In a recent type 2 diabetes sequencing study, we identi-
fied a subset of individuals with unusually large numbers
of heterozygous genotypes and high ratios of heterozygous
genotypes to nonreference allele homozygous genotypes
(HET/HOM ratio) (see Figures 1A and 1B available online).1Department of Biostatistics and Center for Statistical Genetics, School of Pub
Inherited Disease Research, Johns Hopkins University, Baltimore, MD 21224,
3These authors contributed equally to this work
*Correspondence: hmkang@umich.edu
http://dx.doi.org/10.1016/j.ajhg.2012.09.004. 2012 by The American Societ
The AmericanWe hypothesized that some DNA samples might be
contaminated, resulting in poor genotype estimates and
inflated heterozygosity and, therefore, set about to develop
methods to identify such contamination and estimate its
extent.
Here, we describe methods to detect DNA sample con-
tamination based on sequencing and/or array-based geno-
type data.We demonstrate that when sequencing is carried
out on DNA samples for which array-based genotypes are
available, it is possible to estimate the level of sample
contamination, and to identify the source of the contami-
nation (see Web Resources).2 We further demonstrate that
even with low-pass sequencing data alone, we can detect
and estimate the degree of contamination. Finally, and
perhaps most important, we demonstrate that it is possible
to detect even modest levels of DNA sample contami-
nation from array-based genotype data alone, allowing
DNA samples to be prescreened for possible contamination
prior to sequencing. Software based on our methods is
already in use by major sequencing projects, including
the 1000 Genomes Project, and is publicly available (see
Web Resources).Material and Methods
In this section, we first describe a series of methods to evaluate
DNA sample contamination and then outline a series of experi-
ments carried out to evaluate our ability to identify contaminated
samples. We present three likelihood-based methods that detect
DNA sample contamination using (1) sequence data and array-
based genotype data, (2) sequence data alone, and (3) array-based
genotype data alone. We also present a regression-based method
that uses array-based genotype data alone. For each of theselic Health, University of Michigan, Ann Arbor, MI 48109, USA; 2Center for
USA
y of Human Genetics. All rights reserved.
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Table 1. Conditional Probability P(bijjeij gi) of Read bij Given True
Genotype gi, and Read Error eij
True
Genotype gi
Base Calling
Error Event eij Pr(bij ¼ A) Pr(bij ¼ B) Pr(bij ¼ E)b
gi ¼ AAa eij ¼ 0 1 0 0
eij ¼ 1 0 1/3 2/3
gi ¼ ABa eij ¼ 0 1/2 1/2 0
eij ¼ 1 1/6 1/6 2/3
gi ¼ BBa eij ¼ 0 0 1 0
eij ¼ 1 1/3 0 2/3
aAA, AB, BB: A allele homozygote, heterozygote, and B allele homozygote
bE: alleles other than A or B; assumes four possible alleles (bases)methods, we assume that if DNA from a ‘‘contaminating sample’’
represents a fraction a of the observed data, then the same fraction
a of sequence reads and genotype array intensity will be contrib-
uted by the contaminating sample. Initially, we also assume the
presence of no more than one contaminating DNA sample (but
see Discussion).
Detecting Sample Contamination by Using Sequence
Data and Array-Based Genotype Data Jointly
We first consider the simplest situation where a set of genotypes
for each sequenced sample is known and we wish to investigate
whether sequencing reads all originate from the targeted sample
with no evidence for contaminating reads from a different sample.
For each site i, let gi be the true genotype, bij (1% j% Ri) be the base
call for the jth overlapping base (among Ri total reads overlapping
site i and passing mapping and base quality thresholds), and eij be
a latent indicator variable that takes value 0 when bij is called
correctly and 1 otherwise. Assuming that sequencing errors are
equally likely to result in any of the three alternate bases, the
conditional probabilities of observing a specific overlapping base
given the true genotype and error status Pðbij
 gi; eijÞ can be calcu-
lated easily (Table 1). The conditional likelihood of a single over-
lapping base can then be written as the two-samplemixturemodel
P

bij j g1i ; g2i ; eij;a
 ¼ ð1 aÞPbij j g1ij ; eijþ aPbij j g2i ; eij
where g1i and g
2
i are the genotypes of the targeted and contami-
nating DNA samples at site i, and a is the sample contamination
level. Note that, in this section, we assume that array based geno-
types are error-free, and therefore g1i is known. In later sections,
our methods that use either sequence or array-based data alone re-
move this restriction.
In the absence of knowledge of the identity of the contami-
nating individual, we formulate the likelihood
LðaÞ ¼
YM
i¼1
X
εi
X
g1
i
X
g2
i
8<
:
YRi
j¼1
X
eij
P

bij j g1i ; g2i ; eij; εi;a

P

eij
9=;
3P

g2i

P

g1i j εi;Gi

PðεiÞ:
(Equation 1)
Here M is the number of genotyped sites for the targeted indi-
vidual, Gi is the array-based genotype for the targeted individual
at site i, and εi is a binary indicator of genotyping error events.
In Equation 1, we calculate genotype probabilities Pðg2i Þ from pop-
ulation allele frequency estimates assuming Hardy-Weinberg equi-840 The American Journal of Human Genetics 91, 839–848, Novemblibrium, and error probabilities Pðeij ¼ 1Þ ¼ 10Qij=10 and Pðeij ¼
0Þ ¼ 1 10Qij=10 where Qij is the phred-scale base quality score.
For simplicity, we assume Pðg1i ¼ Gi

ε ¼ 0;GiÞ ¼ 1 and Pðg1i ¼
ðGsGiÞjε ¼ 1;GiÞ ¼ 0:5. We estimate the contamination fraction
a by maximizing the likelihood in Equation 1, first using a grid
search on the interval [0, 1] and then applying Brent’s algo-
rithm.3
To identify the contaminating individual among the N study
individuals with array-based genotype data, we consider the likeli-
hood function
Lða; kÞ ¼
YM
i¼1
X
ε
1
i
X
ε
k
i
X
g1
i
X
gk
i
8<
:
YRi
j¼1
X
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
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9=;
P

g1i j ε1i ;Gi

P

gki j εki ;Gi

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ε
1
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i

for individuals 2%k%N. Using maximum likelihood across
a and k, we estimate the most likely contaminating individual k
and contamination level a. By comparing the maximum likeli-
hoods (over a) for the most likely and next most likely contami-
nating samples, including the generic individual represented
by population allele frequencies (as in Equation 1), we obtain a
measure of support for the inferred contaminating individual.
Detecting Sample Contamination by Using Sequence
Data Alone
Next, we consider the problem of identifying contamination
when prior genotype data are not available. In the absence of prior
genotype data, both gi
1 and gi
2 are unknown and the likelihood for
the contamination level a becomes
LðaÞ ¼
YM
i¼1
X
g1
i
X
g2
i
8<
:
YRi
j¼1
X
eij
ð1 aÞPbij j g1i ; eij
þ aPbij j g2i ; eijPeij
9=
;Pg2i Pg1i 
(Equation 2)
Equation 2 can be maximized using an initial grid search fol-
lowed by Brent’s algorithm. In contrast to Equation 1, in which
array-based genotype data are available, Equation 2 is symmetric
with respect to the targeted and contaminating individuals. In
this situation, with sequence data alone and without previously
known genotypes, our method cannot detect sample swaps.
Further, because LðaÞ ¼ Lð1 aÞ here we restrict attention to
0% a% 1/2.
Detecting Sample Contamination by Using
Array-Based Genotype Data Alone
We next turn to the problem of detecting DNA sample contamina-
tion using array-based genotype data alone, an analysis that can be
carried out to identify contaminated samples prior to sequencing.
We assume the availability of relative intensity information, as
produced for example by the Illumina Infinium assay. The
Infinium assay measures the relative intensities of fluorescently
labeled probes associated with arbitrarily labeled alleles A and B.
After normalizing intensities, the Illumina software reports (1)
the genotype as AA, AB, and BB, assigning a missing genotype to
individuals with intensities outside the expected clusters, and (2)
the estimated abundance of the B allele called the B allele
frequency (BAF). We expect BAF close to 0, 1/2, or 1, for genotypes
AA, AB, and BB, respectively. We describe two types of contami-
nation detection, and estimation methods in this setting: twoer 2, 2012
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Figure 1. SNP Genotype Calling and
Estimation of Contamination from 299
European Sequenced Samples Across
chromosome 20
(A) Numbers of heterozygous genotypes.
(B) Ratio of the numbers of nonreference
homozygous genotypes to heterozygous
genotypes (HET/HOM ratio).
(C) Estimated level of DNA sample con-
tamination estimated from sequence data
only.likelihood-based mixture-model methods based on the intensity
values and a regression-based method using BAF as input.
Detecting Sample Contamination byUsing Array Data
Alone—Mixture Models for Intensity Data
We implement our mixture model on the genotype intensity data
in two ways. One implementation estimates model parameters by
examining signal intensity distributions for each marker across all
samples; a second implementation estimates signal intensity
distributions by examining all markers for a single sample. Both
implementations use genotype intensity values normalized by
the GenomeStudio software as input, to reduce technical differ-
ences across samples and markers.
In the multisample implementation, for each marker i, we
model the normalized A and B allele intensity data xiðxA; xBÞ for
an uncontaminated DNA sample as a bivariate Gaussian distribu-
tion:
piðxi j giÞ  N

m
gi
i ;
Xgi
i

; gi ¼ fAA;AB;BBg;1%i%M
Here, gi is again the true genotype at marker i, m
gi
i is the intensity
mean vector for marker i given gi, and
Pgi
i is the covariance matrix
of the A and B allele intensities. We estimate mgii and
Pgi
i using
observed signal intensities and called genotypes at marker i across
all genotyped individuals. To reduce the impact of genotype
misclassification, we exclude samples with call rate <99% and
markers with minor allele frequency <1%. Assuming that the
observed DNA sample is a mixture of two unrelated DNA samples,
we can model the intensity values as a bivariate Gaussian mixture:
pi

xi j g1i ; g2i ;a
  Namg1ii þ amg2ii ;a2Xg1ii
þ ð1 aÞ2
Xg2
i
i

1%i%M
where g1i and g
2
i are the genotypes of the two samples at marker i.
Given data on M independent markers, we formulate the likeli-
hood of a sample using the intensity distribution estimated across
multiple samples as
LðaÞ ¼
YM
i¼1
X
g1
i
X
g2
i
pi

xi j g1i ; g2i

P

g1i

P

g2i

: (Equation 3)
Genotype probabilities Pðgki Þ in Equation 3 can be calculated
assuming Hardy-Weinberg equilibrium using allele frequenciesThe American Journal of Human Genestimated from the called genotypes or
from external data. As before, we estimate
a by maximum likelihood using a grid
search on the interval [0, 1/2] followed by
Brent’s algorithm. With genotype array
data alone,we cannotdetect sample swaps.The single-sample implementation is analogous to the multi-
sample implementation. In the multisample implementation,
the bivariate Gaussian parameters for pi at each marker are esti-
mated across all N samples, whereas in the single-sample imple-
mentation, parameters for pk are estimated across all M markers
called in the individual. The corresponding likelihood of single-
sample implementation follows
LðaÞ ¼
YM
i¼1
X
g1
i
X
g2
i
pk

xi j g1i ; g2i

P

g1i

P

g2i

where pkðxjg1i ; g2i Þ is mixture of bivariate Gaussians whose param-
eters are estimated across all markers for individual k.
The multisample implementation is appropriate when many
samples have been genotyped and can be used to estimate the
distribution of signal intensities for each marker. The single-
sample implementation can be used when data are available on
only one or a few samples.
Detecting Sample Contamination byUsing Array Data
Alone—Regression-Based Method
Our second genotype-array-based method detects contamination
by identifying systematic shifts between the expected, and ob-
served BAF in sites called as homozygous. Consider an individual
with genotype AA whose DNA sample is contaminated. As the
population frequency of the B allele increases, the sample is
increasingly likely to be contaminated with the B allele (Figure 2).
In the case of no contamination, we expect BAF values close to 0,
1/2, and 1 for genotypes AA, AB, and BB, respectively. In the pres-
ence of contamination, we expect for AA and BBhomozygotes that
E½BAF j g ¼ AA;a; pB ¼ apB
E½BAF j g ¼ BB;a; pA ¼ 1 apA
where pA and pB are the population frequencies of A and B and a is
again the contamination level. To estimate contamination, we fit
the linear regression model
BAF ¼ gþ apþ tIðg ¼ AAÞ þ ε (Equation 4)
where g is the intercept, p ¼
	
pB; if g ¼ AA
pA; if g ¼ BB ; t is the difference
in expected BAF between AA and BB genotypes, and ε is a normally
distributed error term. This regression framework allows us toetics 91, 839–848, November 2, 2012 841
Figure 2. Distribution of Array Intensity
for Contaminated and Uncontaminated
Samples
BAF versus population MAF for (A) uncon-
taminated (a ¼ 0) and (B) contaminated
(a ¼ 10%) samples. Normalized intensity
plots for (C) uncontaminated (a ¼ 0) and
(D) contaminated (a ¼ 10%) samples.estimate the contamination level a and to test for contamination
by evaluating the null hypothesis that the slope a ¼ 0 against the
one-sided alternative a > 0.
Instead of using the A or B allele frequency as covariate in the
regression, we instead use the population minor allele frequency
(MAF). This avoids the need to convert Illumina A/B allele calls
to actual A/G/C/T alleles. Letting f be the MAF
PrðB is minor allele j g ¼ AA; f Þ
¼ PrðB is minor allele; g ¼ AA; f Þ
PrðB is minor allele; g ¼ AA; f Þþ PrðA is minor allele; g ¼ AA; f Þ
¼ ð1 f Þ
2
ð1 f Þ2þf 2
so that
E½BAF j g ¼ AA;a; f  ¼ a f ð1 f Þð1 f Þ2þf 2:
Although the relationship between MAF f and contamination
level a is not linear, we found that using a regression model of
the form
BAF ¼ gþ af þ tIðg ¼ AAÞ þ ε
produces nearly identical results to using the model in Equation 4,
which requires knowledge of population allele labels and replaces f
with p (data not shown). Thus, it is possible to detect contamina-
tion using only AB genotypes and without decoding the corre-
spondence between labels A and B and the underlying A, C, G,
and Talleles. This ability to avoid decoding the A and B allele labels842 The American Journal of Human Genetics 91, 839–848, November 2, 2012is important for early steps of data analysis
and quality control which, in this way, can
proceed without worrying about vagaries
of specific genome builds and other infor-
matics challenges that must be tackled
before later rounds of analyses.
Assumptions
For ease of computation and notation,
our models make several assumptions.
The likelihood methods compute likeli-
hoods over multiple markers and/or
aligned base positions, as simple products
of single marker and/or single base call
likelihoods. As written, the resulting likeli-
hoods are strictly correct when sequencing
errors are independent at each aligned base
and markers are in linkage equilibrium;
when these assumptions are violated, the
likelihoods are approximate.4 In practice,
violation of these assumptions can bereduced by: (1) trimming overlapping ends of reads generated
from the same template before analysis, (2) ensuring that variant
sites considered in analysis are adequately spaced (so that it is
unlikely that multiple base calls originating from a single DNA
template are used in analysis), and (3) further trimming marker
lists so they include only markers that are in linkage equilibrium.
In the next section, we discuss empirical assessments of our
method using real data demonstrating that our methods are
highly accurate in real data settings.
Experimental Data
We assessed our contamination estimation and testing methods
using in silico contaminated samples and intentionally contami-
nated real samples.
To evaluate our sequence-based methods, we constructed
in silico contaminated sequence data by randomly mixing aligned
sequence reads from 21 CEU individuals sequenced at ~43
coverage on an Illumina platform as part of the 1000 Genomes
Project. We retained reads from the targeted sample with proba-
bility 1-a, and from the contaminating sample with probability
a ranging from 0.1% to 50%. To avoid artifacts from intrinsic
contamination of the original sequence data, we chose as targeted
samples those with estimated contamination ba < 0.1%. Because
samples had slightly different mean genome coverage and
coverage varied across each genome, the nine levels of intended
contamination a actually varied slightly across the samples. For
all mixture-model-basedmethods, we estimated a using both joint
and sequence-only methods. In both cases, we calculated likeli-
hoods based on sites with MAF > 5% (across 87 CEU samples)
assayed on the Illumina HumanOmni2.5 array using sequence
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Figure 3. Estimated Contamination Levels for In Silico Contaminated Samples
(A) Joint sequence and array-based method, (B) sequence-only method, and (C) between these two methods.reads above phred-scale mapping and base quality thresholds of
13. We based analyses on the entire genome (~1.2M SNPs), chro-
mosome 20 alone (~30K SNPs), or thinned sets of 1,000 to
100,000 evenly spaced SNPs. We also estimated a using our
sequence-only methods based on allele frequency estimates from
89 British (GBR), 93 Finnish (FIN), 381 European (CEU, GBR,
FIN, TSI, IBS), or 246 African (YRI, LWK, ASW) samples to evaluate
the impact of errors in estimated SNP allele frequencies.
To evaluate our genotype-array-only methods, we experimen-
tally constructed contaminated DNA samples by combining pairs
of HapMap CEU individuals and pairs of HapMap YRI individuals.
We targeted six contamination levels, ranging from a ¼ 0 to 10%.
For each contamination level, we targeted three pairs of CEU indi-
viduals, and three pairs of YRI individuals. We genotyped the 36
resulting samples with the Metabochip, an Illumina genotype
array that assays ~200,000 SNPs of interest for studies of cardio-
metabolic traits.5 We used normalized array intensity values,
BAF, and genotypes produced by the Illumina’s GenomeStudio
software run with default options.
Finally, to evaluate empirically our sequence-based methods, we
examined potential contamination in 299 actual DNA samples
sequenced genome-wide by a large sequencing center at ~43
average coverage in a study of type 2 diabetes. One hundred and
fifty samples were sequenced before a change in the sample
handling process in August 2010; the remaining 149 samples
were sequenced after the change. Among 299 sequenced samples,
227 were also genotyped with the Illumina HumanOmni2.5 array.
After quality control of the array data, call rates for each sample
and each SNPwere>98%.We applied our sequence-basedmixture
methods to these data across all SNPs with estimated MAF > 5%.
For these samples, we called genotypes from the sequence data
using glfMultiples6 followed by refinement using BEAGLE.7
From these sequence-based genotype data, we calculated the ratio
of heterozygous genotypes to homozygous nonreference geno-
types (HET/HOM ratio) and genotype discordances with the
HumanOmni2.5 data. All procedures above were approved by
the institutional review boards of the University of Michigan
and proper informed consent was obtained.
Results
Detecting Sample Contamination Using Sequence
Data
We estimated a for the 189 samples constructed with in
silico contamination (0.1%% a% 50%) based on randomThe Americanpairings of 1000 Genomes Project CEU samples (see Mate-
rials and Methods). The estimated contamination level ba
conformed well to the intended contamination level a,
with Pearson correlation coefficient r¼ 0.9996 for the joint
method and r ¼ 0.9840 for the sequence-only method
(Figure 3). Both methods tended to overestimate contami-
nation, especially when a < 1%. Generally, absolute error
jbaaj increasedwithaand relative error jbaaj/adecreased
with a. For example, the absolute error was 0.038% 5
0.024% for the joint method and 0.037% 5 0.021% for
the sequence-only method when a z 0.1% but increased
0.41% 5 0.30% and 0.56% 5 0.55% when a z 10%
(Figure 3). In contrast, the relative error of the estimated
contamination was 0.380 5 0.257 (mean 5 SD) for the
joint method and 0.390 5 0.241 for the sequence-only
method when a z 0.1%, but it was reduced to 0.044 5
0.035 and 0.056 5 0.055 when a z 10%. Finally, for the
sequence-only method, because ba is bounded at 50%, we
observed a downward bias for a near 50%.
We evaluated the impact of estimated population allele
frequencies on accuracy of contamination estimates (Fig-
ure S1). Compared to the original sequence-only estimates
of ba that used CEU allele frequencies, using allele frequen-
cies from the GBR samples resulted in reduced estimates ofba (mean ratio5 SD for baGBR=baCEU ¼ 0.8845 0.083). Allele
frequencies from the more distantly related FIN samples
resulted in further reduced contamination estimates
(mean ratio 5 SD for baFIN=baCEU ¼ 0.804 5 0.135). Allele
frequencies from the broader European (EUR) continental
population (CEU, GBR, FIN, IBS, and TSI) performed better
(mean ratio5 SD for baEUR=baCEU ¼ 0.9265 0.054), whereas
allele frequencies from the very different African (AFR)
samples (YRI, LWK, and ASW) resulted in severe reduc-
tion in contamination estimates (mean ratio 5 SD forbaAFR=baCEU ¼ 0.160 5 0.121).
Next, we evaluated the impact of the number of sites
analyzed on contamination estimates using thinned sets
of 1,000, 10,000 or 100,000 evenly spaced markers and
using only chromosome 20 sites. These smaller numbers
of sites resulted in less accurate estimates of contamina-
tion, particularly at lower levels of contamination (Fig-
ure S2); for example, when a¼ 1%, themean relative errorsJournal of Human Genetics 91, 839–848, November 2, 2012 843
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Figure 4. Estimated Versus Intended
Contamination Levels from the Experi-
mentally Contaminated Array Intensity
Data
Threemethods—regression-basedmethod,
multisample mixture model method, and
single-sample mixture model method—
were compared in two populations (CEU
and YRI).jba  aj/a for the joint method, were 0.414, 0.135, 0.103,
and 0.099 for 1,000, 10,000, 100,000, and all 1.2M sites,
and 0.112 when using the 30,471 chromosome 20 sites.
Because computation times scale linearly with the number
of sites analyzed, an (initial) analysis based on 10,000 sites
or on all chromosome 20 sites requires 120- to 40-times less
computing effort than an analysis of 1.2M sites.
We also compared our joint method to ContEst2 (April
2012 version), which uses genotype and sequence data
together to estimate contamination levels in a likelihood
framework. We obtained very similar results for their
method and ours when a > 1%; when a < 1% ContEst
tended to overestimate contamination levels to a larger
degree than ours (Figure S3).
Estimation and Testing of Sample Contamination
from Genotype Array Data Only
Next, we applied our genotype array-only methods to our
deliberately constructed contaminated samples genotyped
with the Metabochip. Applying the single-sample and
multisample mixture model methods produced contami-
nation level estimates that matched our constructs, except
for two YRI samples with 3% intended contamination
(Figure 4). Estimates from the regression-based method
also showed very strong concordance except for these
same two samples.We observe that the twomixture-model
methods tend to over-estimate a, whereas the regression-
based method tends to underestimate a.
Using the mixture-model methods, 0 of the 6 un-
contaminated CEU samples were identified as contami-
nated, whereas 3 of 6 uncontaminated YRI samples
were identified as slightly (0 < ba < 1%) contaminated.
We suspect that this misclassification is due at least in
part to not having had Metabochip cluster data for
African samples and therefore having used our available
Finnish samples for defining the clusters used in genotype
calling. The mixture-model methods correctly identified
22 of 24 intentionally contaminated samples, the ex-
ceptions being the two YRI samples with 3% intended
contamination.844 The American Journal of Human Genetics 91, 839–848, November 2, 2012Using the regression-basedmethod,
we tested the hypothesis of no conta-
mination across 24 contaminated
and 12 uncontaminated samples at
significance level 0.05/36 ¼ 0.0013;
the results correctly identified the
contamination state of 34 of the 36experimental samples except for the two YRI samples
with intended a ¼ 3%. Given our consistent results across
our three different methods, we suspect that this pair of
YRI samples was not successfully contaminated during
the experimental process.
We evaluated a modified version of our regression-based
methodby including data onheterozygous sites in addition
to homozygous sites or by binning SNPs by MAF; these
modified approaches performed lesswell onboth simulated
and experimental data. The additional noise in the BAF at
heterozygous sites made the estimation of contamination
less accurate. Attempts to smooth out the uneven MAF
distribution of SNPs on a genotype array by binning and
averaging over BAF simply reduced power and failed to im-
prove estimation.We also evaluated the regressionmethod,
restricting analysis to various MAF bins, and observed that
the method performed best when SNPs across the entire
MAF spectrum were included (data not shown).
Type 2 Diabetes Study
As described in the Introduction, in a recent sequencing
study, early in the study we identified a subset of indi-
viduals with unusually large numbers of heterozygous
genotypes and high HET/HOM ratios compared to other
sequenced individuals (Figures 1A and 1B). We applied
our sequence-based and sequence-only methods to these
samples. Because HumanOmni2.5 genotype data were
available on only 227 of these 299 individuals, we display
results for the sequence-only method (Figure 1C); contam-
ination level estimates for the sequence and array data
jointly were very similar, particularly for individuals with
higher contamination levels (Figure 5). Consistent with
our impression based on genotype calls and HET/HOM
ratio, our methods identified a cluster of contaminated
samples among the 150 samples sequenced before August
2010 with 45, 24, and 16 of these 150 samples estimated to
have contamination levels of ba R 1%, R 2%, and R 5%,
respectively (Table 2).
Comparison of results (Figure 1; Table 2; Figure S3)
suggests that our contamination estimates were more
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Figure 5. Estimated Contamination Levels between Sequence-
Based Methods
Comparison of estimated contamination levels using sequence
data with and without array genotype data for type 2 diabetes
sequencing study.sensitive than heterozygosity and HET/HOM ratio for de-
tecting contaminated samples, particularly at lower levels
of contamination. For example, the average HET/HOM
ratios among the ten samples with 2% % ba < 5% and
the 254 samples with ba % 1% were nearly identical: 1.92
and 1.91. Investigation by the sequencing center suggested
that contaminating samples were often in adjacent lanes
to the targeted samples during library construction. Fol-
lowing modification of the library construction process
in August 2010, none of the 149 samples sequenced later
that year had estimated contamination level ba R 0.5%
(Figure 1C).
To assess the impact of DNA sample contamination
on genotyping accuracy, we compared genotypes called
from the diabetes sequence data to the HumanOmni2.5
genotypes. As expected, discordance between the se-
quence-based genotypes and the highly accurate array
genotypes increased with increasing estimated contamina-
tion. For homozygotes, average genotype discordance rates
doubled in samples with 1%% ba% 5% compared to those
with ba % 1% and increased by a factor of ~20 for ba R 5%
(Table 1; Figure 6). The impact of contamination was less
strong for heterozygous sites, but genotype discordance
rates were still nearly doubled when ba R 5% compared
to those in samples with ba % 1%. The stronger effect of
contamination on homozygous genotypes occurs because
even modest numbers of contaminating sequence reads
may result in calling a homozygote as a heterozygote.Discussion
In this paper, we describe several methods to identify
within-species DNA sample contamination based on the
analysis of sequence read data and/or array-based genotype
data. We first describe a mixture-model method that usesThe Americanboth sequence reads and array-based genotypes and then
show that this method can be extended naturally to iden-
tify contaminated samples when only sequence reads are
available. Both these sequence-based methods are highly
sensitive, allowing detection of DNA sample contamina-
tion of 1% or less even with low-coverage (43) sequence
data. As expected, the combination of sequence reads
and array-based genotypes results in greater sensitivity
than sequence data alone, but the difference is modest
(Figure 3). Both of our sequence-based mixture-model
methods are more sensitive than traditional checks that
test for an excess of heterozygous genotypes or an unusu-
ally high ratio of heterozygous to nonreference homozy-
gous genotypes (HET/HOM ratio)—both of which can
only detect contamination rates of >5%–10% (Figure S3).
A further advantage of our sequence-based methods is
that they operate directly on the sequence reads (or BAM
files) and so can be applied prior to variant calling. In
sequencing studies, the availability of array-based geno-
types for all samples allows identification of contami-
nating DNA samples and resolution of sample swaps.
As with other analyses of short read sequence data, the
sequence-based mixture-model methods are computation-
ally intensive. Given low-coverage (43) whole-genome
sequence data and focusing on sites with MAF > 5% from
the Illumina 2.5M genotype array, our sequence-based
analyses required ~1.6 hr compute time per DNA sample
on a single 2.8GHz processor. Increasing sequence coverage
results in an approximate linear increase in compute time.
To reduce computational burden, or if sequence read data
come in large batches, we often do initial DNA contamina-
tion checking using a subset of the genome. For example,
analysis limited to chromosome 20 requires only ~2% the
compute time, thus permitting rapid real-time early quality
control and timely feedback to the sequence production
group; for contamination levels >1% and when the target-
ing and contaminating samples are unrelated, chromo-
some 20 analysis is also nearly as sensitive as analysis of
the entire genome (Figure S2).
Although our analysis of sequence-based methods
focused on low-coverage whole-genome sequences, we
have found that our sequence-based methods robustly
identify contamination in other types of sequencing
data. For example, our methods have been successfully
applied to targeted whole exome sequence data in the
1000 Genomes Project in addition to the low-coverage
sequence data. We also found that our sequence-based
methods robustly detect contamination in RNA-seq data
with or without external genotypes. In these data sets,
focusing on exonic or on-target sites provided more accu-
rate estimates of contamination levels than using all sites
(data not shown).
The models on which we base these methods (of course)
do not capture all features of the sequencing experiment.
One such feature is reference bias, in which more refer-
ence-sequence bases are observed than expected at a
variant site, potentially resulting in an upward bias inJournal of Human Genetics 91, 839–848, November 2, 2012 845
Table 2. Summary of Estimated Contamination Levels ba Ratio of the Numbers of Heterozygous to Nonreference Allele Homozygous
Genotypes, and Genotype Discordance with Array Data for 299 Samples from Type 2 Diabetes Study Using Sequence Data Only
Array Genotypes? Measure
ba (sequence only)
<1% 1%–2% 2%–5% R5%
Yes (n ¼ 227) Number of samples 208 13 1 5
 Before August 2010 81 13 1 5
 After August 2010 127 0 0 0
RR discordancea 0.0021 0.0030 0.0071 0.0492
RA discordanceb 0.0154 0.0157 0.0172 0.0300
AA discordancec 0.0085 0.0143 0.0377 0.176
HET/HOM ratiod 1.92 1.84 2.16 2.66
No (n ¼ 72) Number of samples 46 8 7 11
 Before August 2010 24 8 7 11
 After August 2010 22 0 0 0
HET/HOM ratiod 1.87 1.88 1.88 2.64
aRR discordance: Genotype discordance when array-based genotype is homozygous reference
bRA discordance: Genotype discordance when array-based genotype is heterozygous
cAA discordance: Genotype discordance when array-based genotype in homozygous nonreference
dHET/HOM ratio: Ratio of number of heterozygous genotypes to homozygous nonreference genotypesestimated contamination levels. Poorly aligned bases,
inaccurate base quality scores, and asymmetric calling
errors between bases may have the same effect. Currently,
both our sequence-basedmethods assume that the popula-
tion from which the contaminating sample is drawn
is known, and we observed reduced sensitivity with
incorrect population allele frequencies. When the popula-
tion of the contaminating DNA sample is unknown, our
method could be extended to iterate over alternative pop-
ulation allele frequencies to identify the most likely source
population for a contaminant, and to more precisely esti-
mate the level of contamination. Our implementation
uses a simple error model. Preliminary evaluations of
more sophisticated genotype error models made little
difference to our results.
In several sequencing studies, including the type 2 dia-
betes study described above, we have observed that our
methods estimate a large fraction of samples to be contam-
inated at very low but nonzero levels, and likelihood ratio
tests of a ¼ 0 against the alternative a > 0 result in
apparent ‘‘contamination detection’’ for most samples.
In contrast, when we simulated uncontaminated DNA
samples consistent with all our model assumptions, we
found ba > 0 for only 33% of samples as opposed to 50%
expected by a 1:1 mixture between c0
2 and c1
2 distribu-
tions.8 Furthermore, although both our likelihood-based
methods naturally lead to confidence intervals for the level
of estimated contamination, we generally find these inter-
vals to be too narrow and do not recommend their use.
These contrasting findings likely reflect the impact of not
modeling some of the sequencing experiment features
described above. Careful examination of the impact of un-
certainty in population allele frequency, of variation in846 The American Journal of Human Genetics 91, 839–848, Novembread depth by genotype, of the fraction of duplicate reads,
and of runs of homozygosity, could help to identify impor-
tant features that are missing from the model. We are
working to include some of these features in our models,
methods, and software.
Identifying contaminated samples using array data alone
provides the opportunity to avoid sequencing contami-
nated samples. Both of our genotype-array-only methods –
whether mixture model or regression based–result in
enhanced sensitivity compared to previous strategies that
identify likely contaminated samples as those with low
genotype call rates. Low genotype call rates can identify
heavily contaminated DNA samples as well as those that
fail for other technical reasons. However, in our experimen-
tally contaminated samples genotyped with the Metabo-
chip, even at 5% contamination, all four samples had
genotype call rates > 99.5%, and even at 10% contamina-
tion, call rates were still between 96.8% and 97.9%. Our
mixture- and regression-based methods allowed accurate
detection of contamination levels as low as 1%.
In contrast to the sequence-based methods, our geno-
type-array-only methods have modest computational
requirements. For example, analysis of 36 samples geno-
typed at 200,000 SNPs required <100 seconds on a single
2.8GHz processor for either the mixture-model or regres-
sion-based methods. Further, these genotype-array-only
methods were remarkably sensitive for contamination
detection even with modest numbers of SNPs. For
example, using our experimentally contaminated samples
and defining contamination detection as ba > 1%, power to
detect contamination using the regression method based
on 1,000 random subsets of 50, 100, 500, and 1,000 homo-
zygous SNPs was 37.3%, 59.6%, 99.0%, and 100%,er 2, 2012
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Figure 6. Genotype Discordance between Sequence-Based and Array-Based Genotypes
A function of estimated contamination level ba in the type 2 diabetes sequencing study; contamination level estimates based on the
combined sequence and genotype array data, stratified by genotypes from HumanOmni2.5 array data.
(A) Homozygous reference genotypes, (B) heterozygous genotypes, and (C) homozygous nonreference genotypes.respectively (Table S1). A confidence interval for the esti-
mated contamination level can also be obtained from
a simple linear regression model, ignoring uncertainty in
key parameters such as the site-specific allele frequencies.
We found that, unlike the likelihood-based methods, the
regression-based method provides reliable p value and
confidence interval with even a modest number of SNPs.
Of course, neither genotype-array-based method elimi-
nates the possibility of introducing contamination during
subsequent library preparation or sample sequencing.
Our genotype-array-based mixture-model methods rely
on good estimates of the means and variances of the geno-
type intensity clusters. Estimation can be carried out across
multiple samples (for eachmarker) or using a single sample
(and pooling estimates across markers). The single-sample
method has the obvious advantage that it can be applied to
one or a few samples, permitting analysis to be carried out
for small studies or on-the-fly as each sample is processed;
a further advantage is that the method can analyze rare
genotypes for which intensity distributions may be poorly
estimated in methods that examine intensity distributions
one site at a time, even across many individuals. The
single-samplemethod also has disadvantages. The distribu-
tion of intensities across all SNPs for a given sample gener-
ally has larger variance than that for a given SNP across
many samples;9 for contamination detection, this larger
variance leads to somewhat less sensitive contamination
detection when small numbers of markers are available.
Regularizing parameters that share information across sites
could increase the performance of the intensity-based
mixture models for array data. Compared to the mixture-
model method, the regression method has the advantage
of providing a better calibrated hypothesis test for contam-
ination. In practice, running multiple methods on the
array data will increase the confidence in analysis results.
All our contamination detection methods assume the
targeted DNA sample is contaminated by DNA from one
other unrelated individual. Given a fixed total contamina-
tion level a, contamination from two or more individuals
increases the likelihood that multiple alleles will beThe Americanobserved at a marker and typically results in inflated
estimates of a. For example, when we simulated contami-
nating reads originating from two, three, and four con-
taminating samples, we observed 1%–9%, 4%–11%, and
8%–14% relative increases in the estimated contamina-
tion levels compared to actual contamination (Table S2).
The joint sequence and array-based method, which relies
mostly on genotype concordance rather than increased
heterozygosity, showed only a small loss of precision
with multiple contaminating samples. In contrast, if a
DNA sample is contaminated with DNA from a relative
of the targeted individual, the genetic similarity between
the targeted and contaminating sample will result in an
underestimate of a. Simulation results suggest that given
contamination at level a from an individual sharing a
fraction f of genes with the targeted sample results in an
estimated contamination level of (1-f )a, for example, a/2
for sibling or parent-offspring pairs (data not shown).
There are additional applications not yet covered by
our method. We have implemented and evaluated our
genotype-array-only methods for Illumina genotyping
platform only. In principle, our methods can also support
Affymetrix intensity data, as used in tools such as Bird-
seed10 or PennCNV11, which work with both Affymetrix
and Illumina platforms. For the sequence-based mixture
models, an interesting application would be detection of
heterogeneous cell populations within tumors. Our experi-
ence suggests that even small contamination levels can be
detected using only a small number of informative sites, so
that this might well be practical.
We have described an efficient set of methods to
detect DNA sample contamination that should be useful
for investigators planning or carrying out large-scale
sequencing studies. For studies based on DNA samples
with prior GWAS or other large-scale genotype data, we
recommend using the genotype array-only methods to
detect contaminated samples prior to sequencing. These
methods are useful even for small genotyping arrays with
only thousands of SNPs. Based on results for the geno-
type-array analysis, an investigator may decide to obtainJournal of Human Genetics 91, 839–848, November 2, 2012 847
new DNA samples when there is evidence of contamina-
tion or to eliminate those individuals from the study.
Whether or not the genotype-array-based contamination
prescreening is carried out, we recommend using the
sequence-based methods to screen DNA samples for con-
tamination. Based on the results of this sequence-based
contamination analysis, the investigator might choose to
eliminate from downstream analyses substantially con-
taminated samples or to resample and resequence those
individuals; for example, the 1000 Genomes Project chose
to eliminate all DNA samples with estimated contamina-
tion ba > 2%.12
Application of these DNA contamination detection
methods provides a sensitive method to identify contami-
nated samples and to maximize sequence data quality. In
addition, it may prove helpful to develop analysis methods
that explicitly incorporate detection and estimation of
DNA sample contamination into variant calling and/or
downstream analysis.Supplemental Data
Supplemental Data includes four figures and two tables, and can
be found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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